Novel Approaches for Structural Determination of Cancer Stem Cell Glycans
Novel Approaches for Structural Determination of Cancer Stem Cell Glycans
批准号:
7852331
负责人:
KRISTINA HAKANSSON
金额:
$23.62万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2013-03-31
关键词:
BindingBiological MarkersCancer Vaccine Related DevelopmentCancer VaccinesCancer cell lineCancerousCarbohydratesCause of DeathCell SeparationCell membraneCell surfaceCellsCessation of lifeChargeChemistryCollectionComplexComplex MixturesComplicationCoupledDataDetectionDevelopmentDiseaseDissociationDistantElectronsElectrospray IonizationFlow CytometryFourier transform ion cyclotron resonanceFutureGasesGenerationsGenomicsGlycoproteinsHumanInorganic SulfatesIonsKnowledgeLinkLiquid ChromatographyLocationLymphatic SystemMalignant NeoplasmsMalignant neoplasm of pancreasMass Spectrum AnalysisMembraneMembrane GlycoproteinsMetalsMethodsModelingMolecularNeoplasm MetastasisOligosaccharidesOrganPancreatic AdenocarcinomaPhasePhosphopeptidesPhotonsPlayPolysaccharidesPopulationProliferatingProtein GlycosylationProteinsProteomicsReactionReportingResearchResearch PersonnelResistanceRoleScreening for cancerSialic AcidsSorting - Cell MovementStem cellsStructureSurfaceSurface AntigensSurvival RateTechniquesTherapeuticTherapeutic AgentsTissuesTitaniaUnited StatesUnspecified or Sulfate Ion SulfatesVaccinesVacuumXenograft ModelZirconiumbasecancer cellcancer stem cellcancer therapydivalent metalglycosylationimprovedionizationkillingsmetal oxidemethod developmentmortalitynanonano-electrospraynanoscalenovelnovel diagnosticsnovel strategiesoutcome forecastpublic health relevancesugartumortumor progressiontumor xenografttumorigenicultravioletzirconium oxide
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Pancreatic cancer is expected to cause >32,000 deaths in he United States this year. This high mortality is largely due to lack of reliable methods for early tumor detection, and lack of treatment options that produce a cure. One complication with traditional cancer treatments is that they can easily miss the small subset of cells, termed stem cells, which have been shown to be responsible for a tumor's ability to proliferate. Aberrant protein glycosylation is linked to the onset and progression of cancer. Particularly, acidic glycans with sialic acid and sulfate groups are often altered. Interestingly, recently identified cell surface markers of pancreatic cancer stem cells are glycoproteins. However, due to tremendous analytical challenges associated with structural determination of labile, heterogeneous and branched glycans, detailed cancer-associated glycan structures, which are required for generation of novel diagnostics and therapeutics, including cancer vaccines, are scarce. Mass spectrometry (MS) can provide sensitive and accurate glycan analysis. However, a major challenge in acidic molecule MS is low ionization efficiency. A second challenge is the determination of saccharide branching and specific linkage. Also, sialic acids and sulfate groups are extremely labile, further compromising ionization and rendering sulfate localization difficult. This application focuses on developing novel MS approaches for identifying and structurally characterizing glycans uniquely expressed by pancreatic cancer stem cells (potential biomarkers). Specifically, zirconia and titania surface chemistry will be utilized to enrich sialylated and sulfated glycans from complex mixtures, thereby greatly improving their detection by nano-scale normal phase liquid chromatography Fourier transform ion cyclotron resonance (FTICR) MS. For structural determination of these glycans, we will utilize metal-assisted electron capture dissociation, electron detachment dissociation, and vacuum ultraviolet photodissociation, respectively, to increase sugar cross-ring cleavage, which provides linkage information and therefore allows determination of branched structures, and to determine sulfate location.
PUBLIC HEALTH RELEVANCE: Pancreatic cancer is a major death cause in the United States with a five-year survival rate of <5%. This research focuses on developing novel approaches for improved detection and structural determination of carbohydrates (sugar molecules) present on the surface of pancreatic cancer stem cells, that is, a subset of cells within a tumor that is responsible for its ability to grow and propagate. Carbohydrates are known to be altered in cancer and therefore constitute promising targets for cancer vaccine development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enabling Mass Spectrometry Analysis of the Sulfoproteome
-
批准号:10322358
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2021
-
负责人:KRISTINA HAKANSSON
-
依托单位:
Enabling Mass Spectrometry Analysis of the Sulfoproteome
-
批准号:10543467
-
项目类别:
-
资助金额:$29.92万
-
财政年份:2021
-
负责人:KRISTINA HAKANSSON
-
依托单位:
Enabling Mass Spectrometry Analysis of the Sulfoproteome
-
批准号:10096628
-
项目类别:
-
资助金额:$30.01万
-
财政年份:2021
-
负责人:KRISTINA HAKANSSON
-
依托单位:
Orbitrap Fusion Lumos ETD with IRMPD for UM Chemistry MS Facility Expansion
-
批准号:9075552
-
项目类别:
-
资助金额:$109.52万
-
财政年份:2016
-
负责人:KRISTINA HAKANSSON
-
依托单位:
Targeted Proteomic Approaches for Natural Product Biosynthetic Pathway Discovery
-
批准号:9203060
-
项目类别:
-
资助金额:$28.1万
-
财政年份:2014
-
负责人:KRISTINA HAKANSSON
-
依托单位:
Targeted Proteomic Approaches for Natural Product Biosynthetic Pathway Discovery
-
批准号:8630175
-
项目类别:
-
资助金额:$28.0万
-
财政年份:2014
-
负责人:KRISTINA HAKANSSON
-
依托单位:
Novel Approaches for Structural Determination of Cancer Stem Cell Glycans
-
批准号:8042696
-
项目类别:
-
资助金额:$18.4万
-
财政年份:2010
-
负责人:KRISTINA HAKANSSON
-
依托单位:
Novel Approaches for Structural Determination of Cancer Stem Cell Glycans
-
批准号:8235959
-
项目类别:
-
资助金额:$18.33万
-
财政年份:2010
-
负责人:KRISTINA HAKANSSON
-
依托单位:
海外基金